Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2 $ 156,017 $ (108,484) $ 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs [2] [1] 37 37
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs (in Shares) [2] 27,171      
Stock-based compensation expenses [1] 615 615
Net loss [1] (8,169) (8,169)
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Balance at Dec. 31, 2022 $ 2 157,838 (136,801) 21,039
Balance (in Shares) at Dec. 31, 2022 29,976,582      
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $176 issuance costs [2] [1] 1,293 1,293
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $176 issuance costs (in Shares) [2] 3,199,491      
Stock-based compensation expenses 175 175
Net loss (6,361) (6,361)
Balance at Mar. 31, 2023 $ 2 $ 159,306 $ (143,162) $ 16,146
Balance (in Shares) at Mar. 31, 2023 33,176,073      
[1] Less than $1.
[2] See Note 8A.